| Literature DB >> 30547186 |
Kenichiro Ohnuma1,2, Shimpei Kasagi1,2, Kenichi Uto2, Yoriko Noguchi2, Yuji Nakamachi2, Jun Saegusa1,2, Seiji Kawano3.
Abstract
Receptor activator for nuclear factor κB ligand (RANKL)-independent osteoclastogenic pathway was reported recently. MicroRNA (miR)-124 has been known to suppress RANKL-dependent osteoclastogenesis by inhibiting NFATc1 expression. However, whether miR-124 regulates a RANKL-independent pathway has not been elucidated. In this study, we examined whether a RANKL-independent pathway is regulated by miR-124 in addition to the RANKL-dependent one. Using osteoclastogenic culture and pit-formation assay, we found that a miR-124 mimic inhibited osteoclastogenesis in mouse bone marrow-derived macrophages stimulated by TNF-α, IL-6, and M-CSF in the presence of osteoprotegerin. We also showed that the expression levels of osteoclast-specific genes and NFATc1 protein were suppressed in the miR-124 mimic-transfected cells by performing quantitative-polymerase chain reaction and western blotting. Our results indicate that miR-124 is important in inhibiting both RANKL-dependent and -independent osteoclast differentiation by suppressing NFATc1-mediated pathway.Entities:
Keywords: Interleukin-6; MicroRNA-124; Osteoclast; RANKL-independent osteoclastogenesis; Rheumatoid arthritis; Tumor necrosis factor-α
Mesh:
Substances:
Year: 2018 PMID: 30547186 DOI: 10.1007/s00296-018-4218-7
Source DB: PubMed Journal: Rheumatol Int ISSN: 0172-8172 Impact factor: 2.631